CONNECT WITH US
HealthTech

HealthTech

Can a small DNA fix protect against Parkinson's disease?

Medical Xpress logo

Published on

Add as a preferred source on Google
Can a small DNA fix protect against Parkinson's disease?

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

In 2021, researchers at Oslo University Hospital discovered that by switching off a specific gene in the roundworm C. elegans, they could protect a particular type of nerve cell from age-related degeneration. These are the same types of nerve cells that are affected in patients with Parkinson's disease.

This discovery has prompted researchers to investigate further. Artem Komissarov, a research scientist for SINTEF's Biotechnology and Nanomedicine department, explains, "Much like a precious reference work, our genes contain precise codes for every single protein our body produces. If damage occurs to our genetic material—our DNA—enzymes step in to repair the error.

"This process requires a series of enzymes, each performing a specific task. A bit like the mechanics during a Formula 1 pit stop."

The enzyme that this particular roundworm gene produces plays a crucial role in repairing damaged DNA. However, this error-correction process does not always work to our advantage.

Experiments with human cells show that when this enzyme is absent, the cells' powerhouses—the mitochondria—become more resistant to oxidative stress, which is closely linked to Parkinson's disease.

Researchers at SINTEF are currently working to identify methods to reduce the production of this enzyme. They have developed and tested a synthetic DNA molecule on human cells (HEK293). These experiments were not conducted on nerve cells, but rather on a cell line frequently used in laboratory research.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.